---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "O58bfNgb/nhsri360Ius2bS3myl2X02r3HjrsNS/epP9shMIuc/10aISv8qwYKun/ALvB6PrZqMX0+XgBkVQct7320fIHlJJnAGSSGkZ2OnYCHSN2OHy+MjOLQIBzdRPyqUJCogCov1OmDUJLOS2PXgF5ckzkqzctTJN/FgJHtIMd3wGVe8UZ34OownnI/xcHCNrHq5+7whDX2TQEp8f+LYQOLUpcImFfCiWNoBZuH8cNuOFgGJVPb1YgcY52SbRROhHO1cwMGqP9wP7Dq+2DgQCXHnQIq973g01XUTi3W35bjh5eVwPRavlUfOqfwrM6C7OfeoFpLLoQnEXjr1NI7rkq+Uezxejga0FZRAoD00=;vTpEMoUnou/VGz2jCdslOQ=="
---

